News Focus
News Focus
icon url

ManicTrader

02/20/12 1:31 AM

#196424 RE: ManicTrader #196423

CORT Corcept Therapeutics: FDA approves Korlym for patients with endogenous Cushing’s syndrome- stock is halted (3.03 +0.15) -Update-

Click here for FDA story.
16:20 CORT Corcept Therapeutics halted (3.03 +0.15)
16:17